SECURITIES AND EXCHANGE COMMISSION,
WASHINGTON, D.C. 20549
---------------
SCHEDULE TO
(Rule 14d-100)
TENDER OFFER STATEMENT UNDER SECTION 14(d)(1)
OF THE SECURITIES EXCHANGE ACT OF 1934
(Final Amendment)
AMGEN INC.
--------------------------------------------------------------
(Name of Subject Company (Issuer))
MERIDIAN VENTURE GROUP, LLC
MERIDIAN VENTURE CAPITAL, LLC
MERIDIAN VENTURE GROUP MANAGEMENT, LTD.
--------------------------------------------------------------
Name of Filer and Offeror
CONTRACTUAL CONTINGENT PAYMENT RIGHTS
ARISING FROM THE PURCHASE OF
CLASS A INTERESTS OF AMGEN CLINICAL PARTNERS, L.P.
--------------------------------------------------------------
(Title of Class of Securities)
NONE
------------------------------------------
(CUSIP Number of Class of Securities)
David B. Schmickel
708 Third Avenue, Suite 2010
New York, New York 10017
(212) 688-2015
with copies to:
Steven J. Pierce, Esq.
Pryor Cashman Sherman & Flynn LLP
410 Park Avenue, 10th Floor
New York, New York 10022
(212) 326-0139
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications on Behalf of each Filer)
This Final Amendment amends and supplements the Tender Offer Statement on
Schedule TO, as amended (the "Schedule TO"), filed by Meridian Venture Group,
LLC, a Delaware limited liability company ("Purchaser"), Meridian Venture
Capital, LLC, a Delaware limited liability company, and Meridian Venture Group
Management, Ltd., a New York corporation, relating to the offer by Purchaser to
purchase up to 100 outstanding contractual contingent payment rights arising
from the purchase of Class A Interests of Amgen Clinical Partners, L.P. (the
"CCPRs"), at $280,000 per CCPR, net to the seller in cash, without interest
thereon, on the terms and subject to the conditions set forth in the Offer to
Purchase, dated March 22, 2001 (the "Offer to Purchase"), and in the related
Letter of Transmittal, copies of which have been previously filed as Exhibits
(a)(1) and (a)(2), respectively, of Schedule TO (which, together with any
amendments or supplements hereto or thereto, collectively constitute the
"Offer").
The Offer expired at 12:00 midnight (Eastern Daylight Time) on April 20,
2001. At the time of expiration, 6.5 CCPRs had been tendered and not withdrawn.
Purchaser has accepted for payment all tendered CCPRs, payment for which will be
made promptly.
Signature
After due inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Dated: April 23, 2001
Meridian Venture Group, LLC
By: /s/ David B. Schmickel
------------------------
David B. Schmickel
Meridian Venture Capital, LLC
By: /s/ David B. Schmickel
------------------------
David B. Schmickel
Meridian Venture Group Management, Ltd.
By: /s/ David B. Schmickel
------------------------
David B. Schmickel